- Home
- Endocrinology
- MedX Weekly: CLL Breakthrough, GLP-1 Obesity Update, Rapid Bordetella Test & Nerve Repair Advances
1mo4 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Targeted Therapy for Relapsed CLL/SLL The U.S. Food and Drug Administration granted traditional approval for a targeted therapy for adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphom
MedX Weekly: CLL Breakthrough, GLP-1 Obesity Update, Rapid Bordetella Test & Nerve Repair Advances
2394 Reached1 Comments
Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
